维普中文期刊产品整合服务

Role of the renin angiotensin system in diabetic nephropathy

查看全文 作  者:Tanuj [1]Chawla;Deepika [2]Sharma;Archana [3]Singh 高影响力作者 机构地区:[1]Department of Pharmacology,Lady Hardinge Medical College and Associated Hospitals;[2]Department of Biochemistry,Lady Hardinge Medical College and Associated Hospitals;[3]Department of Biochemistry,University College of Medical Sciences高影响力机构 出  处:《World Journal of Diabetes》索引2010年第1卷第5期,共5页高影响力期刊 摘  要:Diabetic nephropathy has been the cause of lot of mor bidity and mortality in the diabetic population.The renin angiotensin system(RAS) is considered to be involved in most of the pathological processes that result in diabetic nephropathy.This system has var ious subsystems which contribute to the disease pat ho logy.One of these involves angiotensin Ⅱ(Ang Ⅱ) which shows in c reased activity during diabetic nephropathy.This causes hypertrophy of various renal cells and has a pres sor effect on arteriolar smooth muscle resulting in increas ed vascular pressure.Ang Ⅱ also induces inflamm ation,apoptosis,cell growth,migration and differentiation.Monocyte chemoattractant protein-1 production responsible for renal f ibrosis is also regulated by RAS.Polymorphism of angiotensin converting enzym e(ACE) and Angiotensinogen has been shown to have effects on RAS.Available treatment modalities have proven effective in controlling the progression of nephropathy.Various drugs(based on antagonism of RAS) are currently in the market and others are still under trial.Amongst the approved drugs,ACE inhibitors and ang iot ensin receptor blockers(ARBs) are widely used in clinical practice.ARBs are shown to be superior to ACE inhibitors in terms of reducing proteinuria but the combined role of ARBs with ACE inhibitors in diabetic nephropathy is under debate. 关 键 词:DIABETIC NEPHROPATHY ANGIOTENSIN MONOCYTE CHEMOATTRACTANT protein-1 RENIN ANGIOTENSIN sy stem
相关文献

参考文献(62)

引证文献(36)

耦合文献(8)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费